Accesso libero

Comparison of the free and total light chain assays in serum and urine samples with immunofixation electrophoresis for detecting monoclonal proteins in patients with monoclonal gammopathy

INFORMAZIONI SU QUESTO ARTICOLO

Cita

1. Abraham R.S. et al.: Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma. Clin. Chem., 48, 655, 2002.10.1093/clinchem/48.4.655Search in Google Scholar

2. Bradwell A.R. et al.: Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin. Chem., 47, 673, 2001.Search in Google Scholar

3. Bradwell A.R.: Serum Free Light Chain Analysis. 6th ed. Bradwell 2010.Search in Google Scholar

4. Bradwell A.R. et al.: Serum test for assessment of patients with Bence Jones myeloma. Lancet. 361, 489, 2003.10.1016/S0140-6736(03)12457-9Search in Google Scholar

5. Brouwer J., Otting-van de Ruit M., Busking-van der Lely H.: Estimation of free light chains of immunoglobulins by enzyme immunoassay. Clin. Chim. Acta., 150, 267, 1985.Search in Google Scholar

6. Dispenzieri A. et al.: Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood. 111, 785, 2008.10.1182/blood-2007-08-108357220085117942755Search in Google Scholar

7. Dispenzieri A. et al.: Appraisal of immunoglobulin free light chain as a marker of response. Blood. 111, 4908, 2008.10.1182/blood-2008-02-138602296425918364469Search in Google Scholar

8. Herzog W., Hoffman W.: Detection of free kappa and lambda light chains in serum and urine in patients with monoclonal gammopathy. Blood 102, 5190a, 2003.Search in Google Scholar

9. Jaskowski T.D., Litwin C.M., Hill H.R.: Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis. Clin. Vaccine. Immunol., 13, 277, 2006.Search in Google Scholar

10. Jenner E: Serum free light chains in clinical laboratory diagnostics. Clin. Chim. Acta 427, 15, 2014.10.1016/j.cca.2013.08.01823999048Search in Google Scholar

11. Katzmann J.A., Abraham R.S., Dispenzieri A.: Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin. Chem., 51, 878, 2005.Search in Google Scholar

12. Katzmann J.A., Clark R.J., Abraham R.S.: Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin. Chem., 48, 1437, 2002.Search in Google Scholar

13. Katzmann J.A., Kyle R.A., Benson J.: Screening panels for detection of monoclonal gammopathies. Clin. Chem., 55, 1517, 2009.Search in Google Scholar

14. Kendziorek A., Bobilewicz D.M.: Badania laboratoryjne w rożnych stadiach rozwoju gammapatii monoklonalnych. In Vitro Explorer, 1, 3, 2007.Search in Google Scholar

15. Korpysz M. et al.: Concentrations of free light chains determined by nephelometry and turbidimetry. Curr. Iss. Pharm. Med. Sci. 25, 434, 2012.10.12923/j.2084-980X/25.4/a.20Search in Google Scholar

16. Korpysz M., Malecha-Jędraszek A., Donica H.: Blood serum free light chain concentration vs. Immunofixation results in patients with monoclonal gammopathy. Curr. Iss. Pharm. Med. Sci., 25, 430, 2012.Search in Google Scholar

17. Lachmann H.J. et al.: Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br. J. Haematol., 122, 78, 2003.10.1046/j.1365-2141.2003.04433.x12823348Search in Google Scholar

18. Levinson S.S.: Complementarily of urine analysis and serum free light chain assay for assessing response treatment response: illustrated by three case examples. Clin. Chim. Acta., 412, 2206, 2011.10.1016/j.cca.2011.08.01221864518Search in Google Scholar

19. Levinson S.S.: Urine immunofixation electrophoresis remains important and is complementary to serum free light chain. Clin. Chem. Lab. Med., 49, 1801, 2011.10.1515/cclm.2011.64121663562Search in Google Scholar

20. Levinson S.S., Keren D.F.: Free light chains of immunoglobulins: clinical laboratory analysis. Clin. Chem., 40, 1869, 1994.Search in Google Scholar

21. Marien G. et al.: Detection of monoclonal proteins in sera by capillary zone electrophoresis and free light chain measurements. Clin. Chem., 48, 1600, 2002.10.1093/clinchem/48.9.1600Search in Google Scholar

22. Nowrousian M.R. et al.: Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma. Clin. Cancer Res., 11, 8706, 2005.10.1158/1078-0432.CCR-05-048616361557Search in Google Scholar

23. Siegel D. et al.: Inaccuracies in 24-Hour Urine Testing for Monoclonal Gammopathies. Lab. Med., 40, 341, 2009.10.1309/LMXYGLRB6YEBWHCJSearch in Google Scholar

24. Singhal S. et al.: The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios. Blood, 114, 38, 2009.10.1182/blood-2009-02-20580719411633Search in Google Scholar

25. Snozek C.L. et al.: Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system. Leukemia. 22, 1933, 2008.10.1038/leu.2008.171261440618596742Search in Google Scholar

26. Snyder M.R. et al.: Quantification of urinary light chains. Clin. Chem., 54, 1744, 2008.10.1373/clinchem.2008.10759918824580Search in Google Scholar

27. Solling K. et al.: Free light chains of immunoglobulins in serum from patients with leukaemias and multiple myeloma. Scand. J. Haematol., 28, 309, 1982.10.1111/j.1600-0609.1982.tb00532.x6810451Search in Google Scholar

28. Tate J.R. et al.: Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clin. Chim. Acta., 376, 30, 2007.10.1016/j.cca.2006.07.01116945362Search in Google Scholar

29. Usnarska-Zubkiewicz L., Hołojda J., Kuliczkowski K.: Serum free light chain (sFLC) - diagnostic and prognostic value in plasma cell dyscrasias. Acta Haematol. Pol., 40, 349, 2009.Search in Google Scholar

30. Van Hoeven K.H. et al.: Serum free light chain assays are more sensitive than urinary tests for free light chain monoclonal paraproteins. Clin. Chem., 55, C30a, 2009.Search in Google Scholar

31. Viedma J.A., Garrigos N., Morales S.: Comparison of the sensitivity of 2 automated immunoassays with immunofixation electrophoresis for detecting urine Bence Jones proteins. Clin. Chem., 51, 1505, 2005.Search in Google Scholar

eISSN:
2300-6676
ISSN:
2084-980X
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy